Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
BIOD [NASD]
Biodel Inc.
Index- P/E- EPS (ttm)-1.11 Insider Own0.80% Shs Outstand21.14M Perf Week2.67%
Market Cap40.59M Forward P/E- EPS next Y-1.21 Insider Trans9.73% Shs Float20.85M Perf Month-14.67%
Income-19.10M PEG- EPS next Q-0.26 Inst Own27.40% Short Float6.49% Perf Quarter-21.95%
Sales- P/S- EPS this Y35.10% Inst Trans-0.02% Short Ratio8.94 Perf Half Y-39.62%
Book/sh1.16 P/B1.66 EPS next Y-45.80% ROA-49.70% Target Price6.00 Perf Year-57.43%
Cash/sh1.36 P/C1.41 EPS next 5Y- ROE-63.60% 52W Range1.85 - 6.08 Perf YTD-15.79%
Dividend- P/FCF- EPS past 5Y8.60% ROI- 52W High-68.42% Beta2.01
Dividend %- Quick Ratio15.50 Sales past 5Y- Gross Margin- 52W Low3.78% ATR0.10
Employees35 Current Ratio15.50 Sales Q/Q- Oper. Margin- RSI (14)39.39 Volatility4.64% 4.49%
OptionableYes Debt/Eq0.00 EPS Q/Q21.60% Profit Margin- Rel Volume1.26 Prev Close1.89
ShortableYes LT Debt/Eq0.00 EarningsAug 11 Payout- Avg Volume151.48K Price1.92
Recom1.80 SMA20-5.74% SMA50-10.64% SMA200-24.36% Volume190,889 Change1.59%
10-May-13Upgrade Ladenburg Thalmann Neutral → Buy $6
16-Apr-12Upgrade JMP Securities Mkt Perform → Mkt Outperform $3
26-May-11Initiated Global Hunter Securities Accumulate $5
04-Feb-11Reiterated Wedbush Outperform $7 → $5
10-Dec-10Reiterated Wedbush Outperform $10 → $7
02-Nov-10Reiterated Wedbush Outperform $17 → $10
02-Nov-10Downgrade Ladenburg Thalmann Buy → Neutral $14 → $2
19-Oct-10Initiated JMP Securities Mkt Perform
25-Mar-09Reiterated Wedbush Morgan Buy $10 → $16
25-Mar-09Reiterated Ladenburg Thalmann Buy $9.50 → $14
11-Dec-08Reiterated Ladenburg Thalmann Buy $11 → $9.50
20-Nov-08Reiterated Cantor Fitzgerald Buy $33 → $15
19-Sep-08Downgrade Argus Buy → Sell
11-Sep-08Initiated Oppenheimer Perform
08-Sep-08Reiterated Ladenburg Thalmann Buy $23 → $11
16-May-08Initiated Cantor Fitzgerald Buy $33
02-May-08Initiated Pacific Growth Equities Buy
27-Feb-08Initiated JP Morgan Overweight
25-Feb-08Initiated Punk, Ziegel & Co Buy $23
20-Jun-07Initiated Banc of America Sec Buy $23
11-Jun-14 07:30AM  Biodel to Present at the JMP Securities Healthcare Conference Marketwired
07:30AM  Biodel to Present at the JMP Securities Healthcare Conference
10-Jun-14 07:00AM  Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions Marketwired +5.41%
07:00AM  Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions
23-May-14 04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers
21-May-14 12:18PM  BIODEL INC Financials EDGAR Online Financials
12:18PM  BIODEL INC Financials
16-May-14 09:20AM  Biodel Q2 Loss Wider Than Expected Zacks
09:20AM  Biodel Q2 Loss Wider Than Expected
14-May-14 05:18PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05:18PM  BIODEL INC Files SEC form 10-Q, Quarterly Report
13-May-14 08:44PM  Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
08:44PM  Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript
04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition
04:03PM  Biodel reports Q2 EPS (29c), consensus (24c) at theflyonthewall.com
04:03PM  Biodel reports Q2 EPS (29c), consensus (24c)
04:00PM  Biodel Reports Second Quarter Fiscal Year 2014 Financial Results GlobeNewswire
04:00PM  Biodel Reports Second Quarter Fiscal Year 2014 Financial Results
07:07AM  Q2 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
07-May-14 04:00PM  Biodel to Report Second Quarter Fiscal Year 2014 Financial Results on May 13, 2014 GlobeNewswire -5.33%
24-Apr-14 04:30PM  Biodel, HEC Pharm Ink Deal Zacks
22-Apr-14 04:02PM  Biodel announces insulin collaboration pact with HEC Pharm at theflyonthewall.com
04:00PM  Biodel Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation GlobeNewswire
16-Apr-14 12:30PM  Abbott Labs Tops Earnings, Misses Sales Est Zacks
10-Mar-14 04:06PM  BIODEL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
05-Mar-14 07:04PM  On The Fly: After Hours Movers at theflyonthewall.com
04:00PM  Biodel Announces Commercial Manufacturing Agreement With Emergent BioSolutions for Glucagon Rescue Product GlobeNewswire
04-Mar-14 07:00AM  Biodel to Present at the 26th Annual ROTH Conference GlobeNewswire
14-Feb-14 01:04PM  BIODEL INC Financials EDGAR Online Financials
13-Feb-14 04:40PM  Positive Phase I Data from Biodel Zacks
04:40PM  Positive Phase I Data from Biodel
12-Feb-14 04:30PM  Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results GlobeNewswire
10-Feb-14 04:33PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online +8.66%
01:49PM  Biodel Q1 Loss Narrows Zacks
01:49PM  Biodel Q1 Loss Narrows
07-Feb-14 11:33PM  Biodel's CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
11:33PM  Biodel's CEO Discusses F1Q 2014 Results - Earnings Call Transcript
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
06-Feb-14 04:51PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:03PM  Biodel Reports First Quarter Fiscal Year 2014 Financial Results GlobeNewswire
11:40AM  Avanir Reports Narrower Loss, Revs Up Y/Y Zacks
07:07AM  Q1 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
05-Feb-14 04:00PM  Biodel to Report First Quarter Fiscal Year 2014 Financial Results on February 6, 2014 GlobeNewswire
04-Feb-14 04:15PM  Biodel to Present at Upcoming Conferences GlobeNewswire
08-Jan-14 09:28AM  Some Stock Ideas For January 2014 at Seeking Alpha
09:28AM  Some Stock Ideas For January 2014
02-Jan-14 01:11PM  5 Stocks Under $10 Set to Soar at TheStreet +21.49%
01:11PM  5 Stocks Under $10 Set to Soar
10:00AM  Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
10:00AM  Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
27-Dec-13 01:04PM  BIODEL INC Financials EDGAR Online Financials
01:04PM  BIODEL INC Financials
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets TheStreet
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets at TheStreet
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets
20-Dec-13 04:03PM  BIODEL INC Files SEC form 10-K, Annual Report EDGAR Online
04:03PM  BIODEL INC Files SEC form 10-K, Annual Report
19-Dec-13 06:03PM  Nasdaq stocks posting largest volume increases AP
18-Dec-13 09:16PM  Biodel's CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha -5.19%
09:16PM  Biodel's CEO Discusses F4Q 2013 Results - Earnings Call Transcript
04:30PM  Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results GlobeNewswire
04:30PM  Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results
04:06PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:06PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition
07:07AM  Q4 2013 BIODEL INC Earnings Release - 4:30 pm ET CCBN
17-Dec-13 06:02PM  Nasdaq stocks posting largest volume increases AP
08:17AM  Biodel Announces Commercial Supply Agreement With BD for Liquid Glucagon Rescue Device GlobeNewswire
12-Dec-13 07:00AM  Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December 18, 2013 GlobeNewswire
07-Nov-13 04:00PM  InPlay: Biodel advances ultra-rapid-acting concentrated insulin formulation into clinical development Briefing.com
04:00PM  Biodel Advances Ultra-Rapid-Acting Concentrated Insulin Formulation Into Clinical Development GlobeNewswire
24-Sep-13 09:55AM  Biodel CEO Buys 10K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
19-Sep-13 04:40PM  Is Biodel A Buy Or Sell? at Seeking Alpha
12-Sep-13 10:55AM  Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy at Seeking Alpha
11-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP -5.51%
10-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP
05:30PM  Data on Biodel's BIOD-123 Zacks
09-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP -29.82%
02:08PM  Biodel's CEO Presents at Study 3-201Top Line Data Conference Call (Transcript) at Seeking Alpha
12:15PM  Five Highly Unusual Hot Stocks on the Move for Monday 24/7 Wall St.
10:14AM  Biodel Fails to Excite Investors With Me-Too Mealtime Insulin at TheStreet
07:46AM  BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:45AM  InPlay: Biodel: BIOD-123 achieves primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog Briefing.com
08-Sep-13 07:15PM  When Will Unilife Earnings Go Positive? at Motley Fool
05:00PM  Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R) GlobeNewswire
31-Aug-13 11:30AM  Is This a MannKind Killer? at Motley Fool
23-Aug-13 03:36PM  5 Stocks Ready to Break Out at TheStreet
05:00AM  [video] Biotech's Next Big Thing: Fall Trials at TheStreet
21-Aug-13 01:04PM  BIODEL INC Financials EDGAR Online Financials
20-Aug-13 06:11PM  Nasdaq stocks posting largest percentage increases AP
01:19PM  Nasdaq stocks posting largest percentage increases AP
19-Aug-13 06:17PM  Nasdaq stocks posting largest percentage increases AP +8.19%
01:17PM  Nasdaq stocks posting largest percentage increases AP
16-Aug-13 08:35AM  Wider-than-Expected Loss at Biodel Zacks
15-Aug-13 08:30AM  Our BioPharma Catalyst Watch List at Seeking Alpha
14-Aug-13 05:46PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online +8.96%
12-Aug-13 07:45PM  Biodel's CEO Discusses F3Q 2013 Results - Earnings Call Transcript at Seeking Alpha -8.81%
07:45PM  Biodel CEO Discusses F3Q 2013 Results - Earnings Call Transcript at Seeking Alpha
Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. It is involved in developing proprietary insulin formulations for type 1 and type 2 diabetes patients; ultra-rapid-acting insulin analog-based formulations; glucagon formulations and presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia or very low concentrations of blood glucose; and other recombinant human insulin-based formulations. The company was founded in 2003 and is headquartered in Danbury, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pereira Brian JGDirectorDec 20Sale2.264,73410,6990Dec 23 07:21 PM